Lupin reports net profit of Rs 130 crore in Q2 Ruchika Sharma11 Nov 2022 3:30 PM ISTNew Delhi: Drug maker Lupin on Wednesday said its consolidated net profit stood at Rs 130 crore for the second quarter ended September 30, 2022.The...
Lupin gets USFDA nod for generic equivalent of Oracea Capsules Ruchika Sharma8 Nov 2022 5:30 PM ISTORACEA is a tetracycline class drug indicated for the treatment of only inflammatory lesions (papules and pustules) of rosacea in adult patients.
Lupin bags USFDA nod for generic equivalent of Slynd Tablets Ruchika Sharma4 Nov 2022 1:28 PM ISTMumbai: Global pharma major Lupin Limited today announced that the company has received tentative approval from the United States Food and Drug...
Lupin Tarapur facility gets USFDA warning letter Ruchika Sharma3 Nov 2022 1:30 PM IST"This warning letter summarises significant deviations from current good manufacturing practice (CGMP) for active pharmaceutical ingredients (API),"...
USFDA issues 5 observations for Lupin Nagpur facility Ruchika Sharma31 Oct 2022 11:32 AM ISTMumbai: Lupin has recently announced that the US Food and Drug Administration has concluded a Pre-Approval Inspection (PAI) with five observations at...
Lupin unveils Paliperidone ER Tablets in US Ruchika Sharma21 Oct 2022 11:26 AM ISTSchizophrenia is frequently associated with significant distress and impairment in personal, family, social, educational, occupational, and other...
Lupin to acquire two inhalation medicines from Sunovion Pharma for over Rs 623 crore Ruchika Sharma20 Oct 2022 12:15 PM ISTBrovana is indicated for long-term maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease, including...
Lupin gets 17 USFDA observations for Pune facility Ruchika Sharma20 Oct 2022 11:20 AM IST"The Company does not believe that the 483 letter will have an impact on the existing revenues from operations of this facility," Lupin stated.
Lupin, Global Agencies collaborate to support tuberculosis prevention treatment Ruchika Sharma7 Oct 2022 2:30 PM ISTMumbai: Global pharma major, Lupin Limited has announced that it has reached an agreement with Unitaid, The Aurum Institute, the Clinton Health Access...
Dr Shahin Fesharaki appointed as Lupin Global Chief Scientific Officer Ruchika Sharma7 Oct 2022 11:15 AM ISTDr Fesharaki most recently served as the Chief Scientific Officer and Global Head of R&D for Hikma Pharmaceuticals.
Lupin bags USFDA nod for HIV drug Darunavir Ruchika Sharma4 Oct 2022 3:16 PM ISTThe product will be manufactured at Lupin's facility in Nagpur, India.
Lupin gets USFDA EIR for Ankleshwar unit Ruchika Sharma3 Oct 2022 11:28 AM ISTThe inspection of the facility was conducted from August 16-19, 2022.
